Ascendis Pharma A/S (ASND)

Ascendis Pharma A/S ASND

Super Investor & Insider

Nessuna transazione insider negli ultimi 6 mesi.

Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.

About

Ascendis Pharma A/S is a biopharmaceutical company that develops and commercializes therapies for patients with unmet medical needs, with a primary focus on endocrinology and rare diseases. Headquartered in Hellerup, Denmark and founded in 2006, the company uses its TransCon technology platform to modify existing drug …

SectorHealthcare

ExchangeNASDAQ

IndustryBiotechnology

CountryDenmark

Employees1,017

TickerASND

Statistics

Market Cap$14.29B

Revenue (TTM)$954.8M

Net Income—

Net Margin—

EPS—

P/E24.06

P/S14.97

P/B23.15

EV/EBITDA-1306.16

ROE332.7%

Dividend Yield—

Price$231.35

Data: Twelve Data · Revenue = mcap / P/S